America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

Press releases published on June 23, 2026

6 hours ago

Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency

Indeterminate GlobeNewswire

Jun. 23, 2026

JEFFREY OSBORNE-SHEILA E HEADLINE 'SUMMER OF SOUL 2026' BET WEEKEND

Indeterminate EIN Presswire

Jun. 23, 2026

VMD Sciences Launches Global Veterinary Export Pharmacy – Bringing Human-Standard Regulated Access to Animal Medicines

Indeterminate EIN Presswire

7 hours ago

Pocket Network Foundation Co-Authors Ethereum Standard for Decentralized AI Agent Validation

Indeterminate GlobeNewswire

9 hours ago

SK pharmteco kündigt SKyvec™ an: eine integrierte virale Vektorplattform mit hoher Ausbeute zur Beschleunigung der Gentherapie-Entwicklung vom Labor bis zum Patienten

Indeterminate GlobeNewswire

9 hours ago

SK pharmteco lance SKyvec™, une plateforme unifiée de vecteurs viraux à haut rendement destinée à accélérer le développement des thérapies géniques, de la fabrication au patient

Indeterminate GlobeNewswire

9 hours ago

SK pharmteco, 생산 단계부터 환자 치료 현장까지 유전자 치료제 개발 전주기를 지원하는 통합형 고수율 바이럴 벡터 플랫폼 SKyvec™ 출시

Indeterminate GlobeNewswire

10 hours ago

Aeroméxico Announces Webcast of Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

10 hours ago

Bitget lists Arcium (ARX) for Spot Trading

Indeterminate GlobeNewswire

11 hours ago

Bitget Launches Stock+, Bringing Real US Stocks to Crypto-Native Investors

Indeterminate GlobeNewswire

12 hours ago

Sigmatic Sciences Powers AI Scientists with NVIDIA’s Latest BioNeMo Agentic Capabilities

Indeterminate GlobeNewswire

12 hours ago

New Anglia University: Trends Shaping the Future of Graduate Medical Education in the United States

Indeterminate GlobeNewswire

12 hours ago

SK pharmteco Announces SKyvec™, A Unified, High-Yield Viral Vector Platform Designed to Accelerate Gene Therapy Development from Batch to Bedside

Indeterminate GlobeNewswire

13 hours ago

Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome

Indeterminate GlobeNewswire

13 hours ago

Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advancing Nanoparticle-Encapsulated PNKP Inhibitor in Oncology Space

Indeterminate GlobeNewswire

13 hours ago

Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach

Indeterminate GlobeNewswire

13 hours ago

Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial

Indeterminate GlobeNewswire

13 hours ago

Ichnos Glenmark Innovation (IGI) Announces Appointment of Mariana Cota Stirner, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire

13 hours ago

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer 

Indeterminate GlobeNewswire

14 hours ago

Entact Bio Appoints John G. Houston, Ph.D., to its Board of Directors

Indeterminate GlobeNewswire